What is ipamorelin CJC 1295? Learn how this peptide pair is combined, CJC-1295 with DAC vs without DAC, reported effects, dosing claims, and safety facts.
Ipamorelin CJC 1295 is a peptide stack that pairs ipamorelin, a selective growth hormone secretagogue, with CJC-1295, a growth hormone-releasing hormone analog. The goal is to stimulate natural growth hormone release while extending the duration of that signal, which is why cjc 1295 combined with ipamorelin is a popular research pairing. Neither peptide is FDA-approved for human use in the United States.
What Ipamorelin and CJC-1295 Are Individually
Ipamorelin is a synthetic pentapeptide that mimics ghrelin, the hormone that tells the pituitary to release growth hormone. It binds to the ghrelin receptor and triggers a GH pulse. Early research suggests ipamorelin is more selective than older secretagogues, meaning it may cause less appetite increase and less cortisol release.
CJC-1295 is a modified growth hormone-releasing hormone (GHRH) analog. It binds to GHRH receptors on the pituitary and also stimulates GH release. The version called CJC-1295 with DAC has a Drug Affinity Complex that attaches to albumin in the blood, which dramatically extends its half-life.
The search query what is cjc-1295 ipamorelin usually means someone wants to know how these two peptides are paired. Both are sold as research chemicals, not prescription drugs.
Quick Comparison
| Feature | Ipamorelin | CJC-1295 (with DAC) | CJC-1295 (no DAC) |
|---|---|---|---|
| Class | GH secretagogue (ghrelin mimetic) | GHRH analog | GHRH analog (Mod GRF 1-29) |
| Half-life | About 2 hours | About 6–8 days | About 30 minutes |
| FDA-approved for human use? | No | No | No |
| Common research pairing | With CJC-1295 | With ipamorelin | With ipamorelin |
CJC-1295 With DAC vs Without DAC
The question what is cjc-1295 with dac vs without dac comes down to half-life and release pattern. DAC stands for Drug Affinity Complex, which lets CJC-1295 bind to albumin and stay active for days. CJC-1295 without DAC, often called Mod GRF(1-29), has a much shorter half-life of roughly 30 minutes.
CJC-1295 with DAC produces a sustained growth hormone elevation. CJC-1295 without DAC produces more pulse-like release that mimics natural GH rhythms. Researchers choose between them based on the release profile they want to study.
Some people refer to cjc-1295 dac peptide or cjc-1295 with dac peptide when they mean the long-acting version. Others use cjc-1295 without dac / ipamorelin to describe the short-acting pair. These are naming conventions, not different drugs.
Why the Two Peptides Are Combined
The most common research stack is cjc 1295 no dac with ipamorelin, sometimes written ipa/cjc-1295. Ipamorelin triggers a GH pulse, and CJC-1295 without DAC amplifies and extends that pulse. This pairing is popular because the two peptides act on different receptors, which may create a broader GH response than either one alone.
Another option is cjc 1295 with dac and ipamorelin. That combination creates a long, steady GH signal instead of discrete pulses. Some researchers prefer ipamorelin with cjc 1295 without DAC because it more closely mimics the body's natural pulsatile release.
Blends labeled cjc-1295 no dac ipamorelin 10mg or cjc 1295 no dac 5mg ipamorelin 5mg are sold for laboratory research only. Those labels describe the ratio of the two peptides in the vial, not a recommended human dose. A cjc 1295 no dac 10mg vial is simply a larger quantity of the same research chemical.
Common Label Terms and Blend Sizes
If you see cjc 1295 no dac 5mg or cjc 1295 ipamorelin combo, the numbers refer to milligrams of peptide in the vial. The term cjc 1295 plus ipamorelin is another way of saying the two peptides are blended or used together.
Some vendors sell cjc 1295 no dac ipa, which is shorthand for CJC-1295 without DAC plus ipamorelin. None of these labels imply FDA approval or human safety. Product purity and accurate labeling vary widely in the research chemical market.
What Ipamorelin CJC 1295 Is Used For in Research
If you are asking what is cjc 1295 ipamorelin used for, the honest answer is that human data are limited. Most studies on ipamorelin and CJC-1295 were small, short-term, and focused on hormone levels rather than clinical outcomes.
Reported areas of interest include:
- Growth hormone deficiency research
- Body composition and recovery studies in animals
- Age-related declines in GH secretion
- Bone density and collagen research
No large randomized controlled trial has shown that this stack improves athletic performance, body composition, or longevity in healthy adults. Claims about fat loss, muscle gain, or anti-aging effects are not supported by strong human evidence.
Researchers sometimes compare the stack to growth hormone therapy, but the two are not equivalent. Growth hormone therapy is FDA-approved for specific conditions and requires a prescription. Ipamorelin and CJC-1295 are not.
Safety, Side Effects, and Legal Status
Searching what are the side effects of cjc 1295 and ipamorelin returns mostly anecdotal reports and small studies. Commonly mentioned effects include injection site reactions, increased hunger, water retention, headaches, and fatigue.
More serious concerns include potential effects on blood sugar, cortisol, and pituitary hormone feedback. Because these peptides stimulate growth hormone, they could theoretically worsen conditions sensitive to GH, such as diabetes or certain cancers.
A common question, is cjc 1295/ipamorelin fda-approved, has a simple answer: no. Ipamorelin and CJC-1295 are not approved by the FDA for any human indication. They are sold as research chemicals, and human use is not legally sanctioned in the United States.
Anyone considering these peptides should talk to a licensed healthcare professional. Self-dosing with research chemicals carries unknown risks, including product purity issues and dosing errors. Blood work monitoring and medical supervision are essential if a doctor ever supports peptide use in a legal clinical setting.
Bottom Line
Ipamorelin CJC 1295 is a research peptide combination designed to stimulate growth hormone release. CJC-1295 with DAC lasts for days, while CJC-1295 without DAC lasts about 30 minutes and is more commonly paired with ipamorelin.
The stack is not FDA-approved, human evidence is thin, and side effects are not fully characterized. If you are considering it, consult a doctor and prioritize safety over anecdotal claims.
Frequently Asked Questions
Is ipamorelin CJC 1295 FDA-approved?
No. Ipamorelin and CJC-1295 are not FDA-approved for any human use in the United States. They are sold as research chemicals, and human consumption is not legally sanctioned.
What is the difference between CJC-1295 with DAC and without DAC?
CJC-1295 with DAC binds to albumin and has a half-life of about 6–8 days, creating a sustained growth hormone signal. CJC-1295 without DAC, also called Mod GRF(1-29), has a half-life of roughly 30 minutes and produces more pulse-like release.
What are common side effects of ipamorelin and CJC-1295?
Reported side effects include injection site reactions, increased hunger, water retention, headaches, and fatigue. More serious concerns include effects on blood sugar, cortisol, and pituitary hormone feedback. Long-term human safety data are lacking.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.